Publication | Closed Access

A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

HepatologyMedicineLiver PhysiologyGastroenterologyPharmacotherapyAcute Liver FailureLiver DiseaseHepatology FibrosisDose-ranging StudyLiverPharmacologyDrug-induced Liver InjuryDecompensated Liver Cirrhosis